{"id":"https://openalex.org/W6981680814","doi":null,"title":"Estudo in vitro da efic\u00e1cia antineopl\u00e1sica de metformina e de everolimus em monoterapia e terapia combinada com antineopl\u00e1sicos convencionais no tratamento do c\u00e2ncer de ov\u00e1rio","display_name":"Estudo in vitro da efic\u00e1cia antineopl\u00e1sica de metformina e de everolimus em monoterapia e terapia combinada com antineopl\u00e1sicos convencionais no tratamento do c\u00e2ncer de ov\u00e1rio","alternate_titles":[],"publication_year":2013,"publication_date":"2013-11-20","ids":{"openalex":"https://openalex.org/W6981680814"},"language":"pt","primary_location":{"id":"pmh:oai:repositorio.ufes.br:10/4476","doi":null,"is_oa":true,"landing_page_url":"http://repositorio.ufes.br/handle/10/4476","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"instacron:UFES","raw_type":"info:eu-repo/semantics/masterThesis"},"parent_works":[],"lineage":["https://openalex.org/W6981680814"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://repositorio.ufes.br/handle/10/4476","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087014848","display_name":"Taciane Ladislau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I51235708","display_name":"Universidade Federal do Esp\u00edrito Santo","ror":"https://ror.org/05sxf4h28","country_code":"BR","type":"education","lineage":["https://openalex.org/I51235708"]}],"countries":["BR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ladislau, Taciane","raw_affiliation_strings":["Universidade Federal do Esp\u00edrito Santo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Federal do Esp\u00edrito Santo","institution_ids":["https://openalex.org/I51235708"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5087014848"],"corresponding_institution_ids":["https://openalex.org/I51235708"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.5332000255584717,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.5332000255584717,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.43799999356269836,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.015200000256299973,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9639999866485596},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":1.0},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":1.0},{"id":"https://openalex.org/keywords/mtor-inhibition","display_name":"mTOR inhibition","score":0.8970000147819519},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.972000002861023},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7580000162124634},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6700000166893005},{"id":"https://openalex.org/keywords/autophagic-cell-death","display_name":"autophagic cell death","score":0.9610000252723694},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.9229999780654907},{"id":"https://openalex.org/keywords/es-2-cells","display_name":"ES-2 cells","score":0.609000027179718},{"id":"https://openalex.org/keywords/a2780-cells","display_name":"A2780 cells","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.7509999871253967},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.7160000205039978},{"id":"https://openalex.org/keywords/in-vitro-cytotoxicity","display_name":"in vitro cytotoxicity","score":0.5490000247955322},{"id":"https://openalex.org/keywords/cell-viability","display_name":"cell viability","score":0.44200000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8349000215530396},{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.3666999936103821},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.28540000319480896},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.27649998664855957},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.2651999890804291},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2605000138282776},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24729999899864197},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.23399999737739563},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.22439999878406525},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.19689999520778656},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.1655000001192093},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.16369999945163727},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.16290000081062317},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.15230000019073486},{"id":"https://openalex.org/C2777209026","wikidata":"https://www.wikidata.org/wiki/Q412405","display_name":"Inflammasome","level":3,"score":0.15150000154972076},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.14329999685287476},{"id":"https://openalex.org/C183713625","wikidata":"https://www.wikidata.org/wiki/Q5282002","display_name":"Discovery and development of mTOR inhibitors","level":4,"score":0.13920000195503235},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.13850000500679016},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.13089999556541443},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.1307000070810318},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.12780000269412994},{"id":"https://openalex.org/C2776307423","wikidata":"https://www.wikidata.org/wiki/Q425027","display_name":"Glimepiride","level":4,"score":0.1274999976158142},{"id":"https://openalex.org/C81182388","wikidata":"https://www.wikidata.org/wiki/Q353963","display_name":"Complication","level":2,"score":0.12729999423027039},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.12559999525547028},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.12520000338554382},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.11909999698400497},{"id":"https://openalex.org/C2780791683","wikidata":"https://www.wikidata.org/wiki/Q846785","display_name":"Action (physics)","level":2,"score":0.11840000003576279},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.11739999800920486},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.11659999936819077},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.11490000039339066},{"id":"https://openalex.org/C40993552","wikidata":"https://www.wikidata.org/wiki/Q514654","display_name":"Gold standard (test)","level":2,"score":0.1120000034570694},{"id":"https://openalex.org/C130840561","wikidata":"https://www.wikidata.org/wiki/Q2344000","display_name":"Dot blot","level":3,"score":0.11060000211000443},{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.11060000211000443},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.10970000177621841},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.10890000313520432},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.10890000313520432},{"id":"https://openalex.org/C2775934546","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Biopsy","level":2,"score":0.10779999941587448},{"id":"https://openalex.org/C2778826181","wikidata":"https://www.wikidata.org/wiki/Q3310538","display_name":"Culprit","level":3,"score":0.10779999941587448},{"id":"https://openalex.org/C2987828669","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical study","level":2,"score":0.10729999840259552},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.10480000078678131}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:repositorio.ufes.br:10/4476","doi":null,"is_oa":true,"landing_page_url":"http://repositorio.ufes.br/handle/10/4476","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"instacron:UFES","raw_type":"info:eu-repo/semantics/masterThesis"},{"id":"pmh:oai:americanae.aecid.es:1532288","doi":null,"is_oa":true,"landing_page_url":"http://repositorio.ufes.br/handle/10/4476","pdf_url":null,"source":{"id":"https://openalex.org/S4306400786","display_name":"Americanae (AECID Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"reponame:Reposit\u00f3rio Institucional da UFES","raw_type":"info:eu-repo/semantics/masterThesis"}],"best_oa_location":{"id":"pmh:oai:repositorio.ufes.br:10/4476","doi":null,"is_oa":true,"landing_page_url":"http://repositorio.ufes.br/handle/10/4476","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"instacron:UFES","raw_type":"info:eu-repo/semantics/masterThesis"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321091","display_name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","ror":"https://ror.org/00x0ma614"},{"id":"https://openalex.org/F4320322025","display_name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","ror":"https://ror.org/03swz6y49"},{"id":"https://openalex.org/F4320323682","display_name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa e Inova\u00e7\u00e3o do Esp\u00edrito Santo","ror":"https://ror.org/03cen2c33"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W6981680814.pdf","grobid_xml":"https://content.openalex.org/works/W6981680814.grobid-xml"},"referenced_works_count":145,"referenced_works":["https://openalex.org/W1859354334","https://openalex.org/W1918384196","https://openalex.org/W1964423199","https://openalex.org/W1966932597","https://openalex.org/W1967051331","https://openalex.org/W1968704850","https://openalex.org/W1969157667","https://openalex.org/W1970550717","https://openalex.org/W1971579914","https://openalex.org/W1973668609","https://openalex.org/W1974584534","https://openalex.org/W1974888028","https://openalex.org/W1975317091","https://openalex.org/W1976033985","https://openalex.org/W1977600616","https://openalex.org/W1978608178","https://openalex.org/W1981711832","https://openalex.org/W1982845383","https://openalex.org/W1983698019","https://openalex.org/W1985046929","https://openalex.org/W1987005832","https://openalex.org/W1987940280","https://openalex.org/W1988943434","https://openalex.org/W1991052457","https://openalex.org/W1994504180","https://openalex.org/W1996474536","https://openalex.org/W1996518952","https://openalex.org/W1996641308","https://openalex.org/W1996713943","https://openalex.org/W1998203489","https://openalex.org/W2003851398","https://openalex.org/W2006559495","https://openalex.org/W2006771504","https://openalex.org/W2007095168","https://openalex.org/W2008908425","https://openalex.org/W2010183849","https://openalex.org/W2012733679","https://openalex.org/W2013374433","https://openalex.org/W2017479637","https://openalex.org/W2019576484","https://openalex.org/W2022292123","https://openalex.org/W2023012828","https://openalex.org/W2025480694","https://openalex.org/W2025980697","https://openalex.org/W2026967508","https://openalex.org/W2028050295","https://openalex.org/W2032870664","https://openalex.org/W2034852369","https://openalex.org/W2035929416","https://openalex.org/W2040330598","https://openalex.org/W2041216149","https://openalex.org/W2041888407","https://openalex.org/W2042196308","https://openalex.org/W2045250791","https://openalex.org/W2051320284","https://openalex.org/W2052425409","https://openalex.org/W2052633507","https://openalex.org/W2052902650","https://openalex.org/W2053793483","https://openalex.org/W2055827129","https://openalex.org/W2056040807","https://openalex.org/W2059019158","https://openalex.org/W2059143304","https://openalex.org/W2060905299","https://openalex.org/W2062006818","https://openalex.org/W2065827854","https://openalex.org/W2065887259","https://openalex.org/W2065889524","https://openalex.org/W2070369494","https://openalex.org/W2071188087","https://openalex.org/W2071755099","https://openalex.org/W2075711878","https://openalex.org/W2076450855","https://openalex.org/W2078523315","https://openalex.org/W2078532650","https://openalex.org/W2080100938","https://openalex.org/W2080297266","https://openalex.org/W2080680563","https://openalex.org/W2081920342","https://openalex.org/W2087136249","https://openalex.org/W2090859762","https://openalex.org/W2091896084","https://openalex.org/W2092440654","https://openalex.org/W2092999618","https://openalex.org/W2093664485","https://openalex.org/W2095454212","https://openalex.org/W2097105130","https://openalex.org/W2099031084","https://openalex.org/W2099521317","https://openalex.org/W2101083009","https://openalex.org/W2102702411","https://openalex.org/W2102799140","https://openalex.org/W2102891343","https://openalex.org/W2103540939","https://openalex.org/W2103816214","https://openalex.org/W2105223251","https://openalex.org/W2106767659","https://openalex.org/W2109600717","https://openalex.org/W2109776859","https://openalex.org/W2114349038","https://openalex.org/W2114859236","https://openalex.org/W2116316656","https://openalex.org/W2117398014","https://openalex.org/W2118677643","https://openalex.org/W2120071388","https://openalex.org/W2121754497","https://openalex.org/W2125747634","https://openalex.org/W2126783165","https://openalex.org/W2127758887","https://openalex.org/W2127812467","https://openalex.org/W2130160735","https://openalex.org/W2130941707","https://openalex.org/W2133506440","https://openalex.org/W2133540186","https://openalex.org/W2136676465","https://openalex.org/W2137226085","https://openalex.org/W2137373982","https://openalex.org/W2141065273","https://openalex.org/W2142504521","https://openalex.org/W2143219457","https://openalex.org/W2144209522","https://openalex.org/W2151807108","https://openalex.org/W2152289580","https://openalex.org/W2153493705","https://openalex.org/W2153607816","https://openalex.org/W2154515817","https://openalex.org/W2155191323","https://openalex.org/W2156370651","https://openalex.org/W2157000986","https://openalex.org/W2157983986","https://openalex.org/W2162645859","https://openalex.org/W2165523894","https://openalex.org/W2165982968","https://openalex.org/W2166162078","https://openalex.org/W2166779240","https://openalex.org/W2168809345","https://openalex.org/W2169859012","https://openalex.org/W2171979623","https://openalex.org/W2171998898","https://openalex.org/W2317055602","https://openalex.org/W2324992560","https://openalex.org/W2328421677","https://openalex.org/W3101991337","https://openalex.org/W4237115449","https://openalex.org/W4238567307"],"related_works":["https://openalex.org/W2564196843","https://openalex.org/W3080994564","https://openalex.org/W4367294721","https://openalex.org/W2050865113","https://openalex.org/W3165552809","https://openalex.org/W3200047656","https://openalex.org/W2891117532","https://openalex.org/W2942017229","https://openalex.org/W2973127650","https://openalex.org/W129875519"],"abstract_inverted_index":{"Ovarian":[0],"cancer":[1],"(CAOV)":[2],"is":[3],"the":[4,8,14,38,42,66,77,93,116,126,133,160,168,231,263,271],"most":[5],"lethal":[6],"of":[7,16,37,68,79,84,89,118,170,199,222,247,266,273,278],"gynecologic":[9],"malignancies,":[10],"partially":[11],"due":[12],"to":[13,46,142,149,185],"lack":[15],"specific":[17],"signs":[18],"and":[19,40,52,81,98,108,137,157,164,174,195,218,239,242,251,256,268],"symptoms":[20],"as":[21,23,65],"well":[22],"diagnosis":[24],"strategies":[25],"insufficient.":[26],"Most":[27],"women":[28],"affected":[29],"by":[30,106],"CAOV":[31,94],"are":[32],"diagnosed":[33],"in":[34,92,110,113,130,132,139,155,159,192,234,249,270],"advanced":[35],"stages":[36],"disease,":[39],"despite":[41],"initial":[43],"satisfactory":[44],"response":[45],"antineoplastic":[47],"drugs,":[48],"eventually":[49],"develop":[50],"chemoresistance":[51],"recurrence.":[53],"Therefore,":[54],"new":[55],"therapeutic":[56],"agents":[57],"which":[58],"focus":[59],"on":[60,216],"molecular":[61],"targets":[62],"has":[63],"emerged":[64],"prospect":[67],"better":[69],"prognosis":[70],"CAOV.":[71],"In":[72,229],"this":[73],"context,":[74],"we":[75,212],"investigated":[76],"action":[78,215],"metformin":[80,107,121,171,238,255,267],"everolimus,":[82],"modulators":[83],"protein":[85],"kinase":[86],"Mammalian":[87],"Target":[88],"Rapamycin":[90],"(mTOR)":[91],"cell":[95,101,134,161,227],"lines":[96,162],"ES-2":[97,163,193],"A2780.":[99],"Metabolic":[100],"viability":[102],"(VCM)":[103],"was":[104,128,202,244],"reduced":[105,129],"everolimus":[109,145,175,207,240,257,269],"different":[111],"concentrations,":[112],"addition":[114],"intensifying":[115],"effect":[117],"paclitaxel.":[119],"Combining":[120],"10\u00b5M":[122],"with":[123,237,254],"taxane":[124,186],"100nM":[125],"VCM":[127,154,183,217],"56,55%":[131],"line":[135],"ES-2,":[136],"71,38%":[138],"A2780":[140],"compared":[141],"control.":[143],"Similarly,":[144],"0,06":[146],"nM":[147,152],"added":[148],"paclitaxel":[150,179],"100":[151],"decreased":[153],"66,4%":[156],"73,38%":[158],"A2780,":[165],"respectively.":[166,259],"Moreover":[167],"maintenance":[169],"dose":[172],"(10\u00b5m)":[173],"(0,06nM)":[176],"associated":[177],"whith":[178],"12,5nM":[180],"promoted":[181],"a":[182,196,275],"compatible":[184],"100nM.":[187],"We":[188],"performed":[189],"anexinaV/PI":[190],"assay":[191],"lineage,":[194],"low":[197],"percentage":[198],"apoptotic/necrotic":[200],"cells":[201,232,248],"induced":[203],"(metformin":[204],"10\u00b5M,":[205],"4.35%/3.85%;":[206],"0,06nM,":[208],"1.25%/5.1":[209],"%),":[210],"however,":[211],"found":[213],"its":[214],"thus":[219],"suggest":[220],"occurrence":[221],"additional":[223],"processes,":[224],"such":[225],"autophagic":[226],"death.":[228],"addition,":[230],"predominated":[233],"phase":[235,253],"GO/G1":[236],"treatment,":[241,258],"there":[243],"an":[245],"increase":[246],"G2/M":[250],"sub-G0":[252],"Our":[260],"findings":[261],"highlight":[262],"potential":[264],"application":[265],"treatment":[272],"CAOV,":[274],"major":[276],"challenge":[277],"clinical":[279],"oncology":[280]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W6981680814","counts_by_year":[],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2025-10-10T00:00:00"}
